PHAR2

Welcome to the HAL collection
of thePHAR2 Laboratory – U1070

PHAR2 – Pharmacologie des anti-infectieux et antibiorésistance = Pharmacology of Antimicrobial Agents and antibioResistance –, is a research unit affiliated to the University of Poitiers and INSERM.

It has been created in 2012 and is located on the University Campus of Poitiers (France).

The objective of PHAR2 laboratory is to develop innovative PK/PD modelling approaches to select the best dosing regimen of antibiotics administered alone or in combination as well as the best route of administration and best formulation, in order to increase antimicrobial efficacy and limit bacterial resistance.

PHAR2 laboratory conducts translational research, from cells culture models to patients, and integrating microbiology, analytical chemistry, drug formulation, and in vivo preclinical experiments.

To date, PHAR2 laboratory received grants from Region Nouvelle Aquitaine, ANR, PHRC, JPIAMR, IMI, and CPER-FEDER and has established collaborations with ANSES and several Universities in France (Paris Sud, Paris Diderot) and abroad (Dublin, Erasmus MC, Upssala, Hambourg, Catholic University of Louvain…), as well as leading pharmaceutical companies.

Evolution of deposits

Deposits by document type